Breaking News, Promotions & Moves

CPTx Appoints McDavid Stilwell as Chief Financial Officer

Stilwell joins CPTx to oversee the company’s financial strategy and operations, investor relations, and business development functions.

Author Image

By: Charlie Sternberg

Associate Editor

CPTx GmbH, a pioneer in the therapeutic development and manufacturing of novel medicines built with single-stranded DNA, has appointed McDavid Stilwell as Chief Financial Officer. Stilwell joins CPTx to oversee the company’s financial strategy and operations, investor relations, and business development functions to support the company’s goals of advancing its in vivo CAR-T program into clinical development in 2027 and developing its novel gene nanocarrier to be “partner ready” in 2026. St...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters